IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FOCA', Emanuele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.099
EU - Europa 3.034
AS - Asia 1.886
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 13
SA - Sud America 10
Totale 11.076
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.072
CN - Cina 813
IT - Italia 680
UA - Ucraina 642
SG - Singapore 530
DE - Germania 437
PL - Polonia 347
HK - Hong Kong 281
FI - Finlandia 236
GB - Regno Unito 194
RU - Federazione Russa 189
TR - Turchia 160
IE - Irlanda 141
FR - Francia 55
SE - Svezia 39
IN - India 28
CA - Canada 24
CZ - Repubblica Ceca 24
BE - Belgio 17
VN - Vietnam 17
EU - Europa 14
ID - Indonesia 14
NL - Olanda 13
AU - Australia 12
JP - Giappone 9
BF - Burkina Faso 4
CI - Costa d'Avorio 4
IR - Iran 4
MK - Macedonia 4
PE - Perù 4
UG - Uganda 4
BD - Bangladesh 3
ES - Italia 3
KR - Corea 3
KZ - Kazakistan 3
MY - Malesia 3
TH - Thailandia 3
BR - Brasile 2
CH - Svizzera 2
CM - Camerun 2
IL - Israele 2
LK - Sri Lanka 2
MU - Mauritius 2
NG - Nigeria 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MS - Montserrat 1
MX - Messico 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SL - Sierra Leone 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 11.076
Salva come PNG Salva come JPEG
Città #
Fairfield 842
Woodbridge 618
Jacksonville 520
Singapore 441
Ashburn 412
Houston 399
Chandler 380
Warsaw 346
Seattle 344
Wilmington 341
Ann Arbor 319
Cambridge 299
Hong Kong 278
Princeton 265
Helsinki 178
New York 168
Nanjing 164
Istanbul 144
Beijing 138
Dublin 138
Brescia 119
Moscow 71
Dearborn 62
Des Moines 60
Shanghai 58
Nanchang 52
Milan 50
San Diego 47
Tianjin 47
Jinan 44
Shenyang 42
Changsha 39
Hebei 37
Lancaster 32
London 29
Boardman 28
Jiaxing 25
San Francisco 25
Brno 21
Hangzhou 21
Munich 21
Zhengzhou 20
Los Angeles 19
Ningbo 19
Kunming 18
Taizhou 17
Toronto 17
Brussels 16
Dong Ket 16
Washington 16
Bologna 15
Rome 15
Verona 15
Romola 13
Falkenstein 12
Jakarta 10
Orange 10
Falls Church 9
Kocaeli 9
Lappeenranta 9
Florence 8
Haikou 8
Napoli 8
Nürnberg 8
Taiyuan 8
Tokyo 8
Trento 8
Monmouth Junction 7
Norwalk 7
Ravenna 7
Augusta 6
Fuzhou 6
Padova 6
Parma 6
Torino 6
Canberra 5
Dallas 5
Espoo 5
Kilburn 5
Melbourne 5
Redwood City 5
San Mateo 5
Santa Clara 5
Abidjan 4
Chiswick 4
Collegno 4
Frankfurt am Main 4
Glasgow 4
Gorle 4
Guangzhou 4
Lanzhou 4
Lima 4
Mountain View 4
Paris 4
Redmond 4
Acton 3
Almaty 3
Amsterdam 3
Bangkok 3
Buccinasco 3
Totale 8.149
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 234
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 218
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 197
Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm 182
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 168
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 168
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 150
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 150
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 148
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 142
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 142
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 141
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 140
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 137
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 133
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 131
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 129
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 128
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 123
Phenotypic and genotypic evaluation of slime production by conventional and molecular microbiological techniques 117
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 116
Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study. 114
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 114
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 114
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 113
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 112
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 112
Virological effectiveness and CD4+ T-cell increase over early andlate courses in HIV infected patients on antiretroviral therapy: focus on HCV andanchor class received 110
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? 107
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort 107
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 104
High prevalence of radiological vertebral fractures in HIV-infected males 104
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 104
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 104
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 103
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: An Italian randomized clinical trial 103
Malaria prophylaxis. A comprehensive review 102
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 102
UVA1 phototherapy as a treatment option for plaque psoriasis in HIV-positive patients 102
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 101
Malaria and HIV in adults: When the parasite runs into the virus 101
DTG prescribing patterns in PLWH ≥65 years: the impact of 2DR and weight gain 100
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 99
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 97
The good, the bad and the ugly: Determinants of antiretroviral-associated toxicities 97
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 95
Management of neurocysticercosis in Northern Italy: presentation of 11 cases and review of the literature on an emerging infection 94
Adverse events associated to HAART in Burkina Faso 93
Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection. 93
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 93
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 93
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study 92
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: Results of a 3-year cohort study 89
Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of Hepatocellular carcinoma (HCC): a single-centre study 88
HIV/HBV and HIV/HCV co-infection in Burkina Faso, West Africa 86
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir 86
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 86
Coinfezione HIV/HBV in Burkina Faso, Africa Occidentalele 85
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 85
The use of ultrasonography, transient elestography, APRI and FIB-4 to measure liver steatosis and fibrosis in HIV-positive patients not co-infected with hepatitis viruses with hypertransaminasemia of unknown origin on HAART 84
Elderly women with human immunodeficiency virus infection: is there an effect of the virus on neuropsychological prolife? 83
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 81
Perinatally HIV-Infected Youths After Transition from Pediatric to Adult Care, a Single-Center Experience from Northern Italy 79
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 79
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 79
International migrations and HIV care in the rural District of Nanoro, Burkina Faso 78
Drug-specific risk of adverse events onset related to HAART in a resource-limited setting from 2001 to 2009: the experience of 3 medical centers in Burkina Faso 76
Disengagement and reengagement of HIV continuum of care in a single center cohort in northern Italy 76
Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience 76
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression (The Patient - Patient-Centered Outcomes Research, (2020), 13, 3, (375-387), 10.1007/s40271-020-00413-y) 76
Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic 74
Coming home to be cared. Emigration and antiretroviral treatment in the Nanoro health District, Burkina Faso 73
Sexuality, pregnancy and procreation desire among HIV+ patients in Ouagadougou, Burkina Faso 73
Coming home to be cared. Emigration and antiretroviral treatment in the Nanoro health district, Burkina Faso. 73
Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART 73
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort 73
Amebiasi e infezione da amebe a vita libera 72
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 71
Infezioni intestinali da protozoi e tricomoniasi 70
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 70
SARS-CoV-2 invades the West. How to face a COVID-19 epidemic in Lombardy, Northern Italy? 67
User fees and compliance to HAART in Ouagadougou, Burkina Faso 65
Pregnancy related immune-deficit in HIV-infected pregnant women in resource-limited countries. Implications for HAART initiation 63
Monitoring the toxicity related to HAART from 2001 to 2009 in Burkina Faso: clinical adverse events vs. laboratori adverse events: prevalence, grading and outcome 63
Six cases of sepsis caused by Pantoea agglomerans in a teaching hospital 63
Unboosted Atazanavir for Treatment ofHIV Infection: Rationale and Recommendations for Use 62
Febbri emorragiche virali ed altre arbovirosi 62
P. falciparum malaria recrudescence in a cancer patient 60
Qualitative and quantitative analysis of mortality and morbidity at the health facilities in the rural district of Nanoro, Burkina Faso 60
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? 60
Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV 60
Infezioni da cestodi 59
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 59
Infezioni da nemtodi e filariosi 58
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 55
Problematiche ed esigenze di intervento in campo sanitario 53
Confronto della efficacia della TARV tra popolazione urbana e rurale in un contesto a risorse limitate 53
Lotta all'AIDS in Burkina Faso 51
I farmaci antiparassitari 50
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 49
Totale 9.739
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.485 0 0 0 0 0 250 212 245 164 370 93 151
2020/20212.081 42 294 96 219 111 231 117 228 207 272 185 79
2021/20221.200 85 156 25 77 42 71 74 89 67 134 103 277
2022/20231.129 150 18 22 78 107 280 5 119 207 8 69 66
2023/20241.352 87 27 113 105 64 244 59 60 305 24 39 225
2024/20251.118 38 36 33 413 305 293 0 0 0 0 0 0
Totale 11.472